Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contributions of Mild Traumatic Brain Injury to Neurodegeneration Due to Chronic Traumatic Encephalopathy and Alzheimers Disease

NCT04124029 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04124029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04124029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contributions of Mild Traumatic Brain Injury to Neurodegeneration Due to Chronic Traumatic Encephalopathy and Alzheimers Disease
Lead sponsor
VA Office of Research and Development
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2021
Completion date
December 31, 2026
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment, mild traumatic brain injury, moderate traumatic brain injury